Review Article

人类猴痘病毒感染的预防和管理研究进展

卷 24, 期 13, 2023

发表于: 12 October, 2023

页: [1032 - 1045] 页: 14

弟呕挨: 10.2174/0113894501258154231008194028

价格: $65

conference banner
摘要

背景:在过去几十年中,有几种被忽视的传染性病原体再次出现,包括猴痘病毒,这是一种来自正痘病毒属的病毒,可导致猴痘,并在动物和人类之间传播。人类猴痘疫情已经蔓延到几个不同的国家。由于此次疫情的病例数异常高,而且与流行国家缺乏联系,人们担心猴痘的传播模式可能已经改变。 目的:本研究旨在提供人类猴痘病毒预防和管理的最新进展。 方法:我们在这项工作中强调了在预防和管理人类猴痘病毒方面的最新进展。 结果:为了治疗和预防猴痘,正在使用新的药物和疫苗,需要进行更多的研究来了解猴痘流行地区的流行病学、生物学和生态学,并阻止未来的全球疫情。市场上可用于治疗病毒的疫苗有JYNEOS和ACAM2000。一些抗病毒药物,如替卡韦、布林西多福韦、西多福韦、三氟吡啶和牛痘免疫球蛋白,用于治疗猴痘病毒。一些疫苗,如NIOCH-14、西多福韦、CMX-001和ST-246,目前正在进行临床试验。 结论:本文涵盖了猴痘病毒生物学的特征,这些特征对风险评估和猴痘病毒爆发的准备工作很重要,重点介绍了病毒宿主范围、进化潜力和潜在中和靶点的最新进展。

关键词: 猴痘病毒,病理生理学,预防,治疗,临床试验化合物,感染。

图形摘要
[1]
Patel A, Bilinska J, Tam J C, et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: De scriptive case series. bmj 2022; 378: e072410.
[http://dx.doi.org/10.1136/bmj-2022-0724108] [PMID: 35902115]
[2]
Mourya D, Yadav P, Ullas PT, et al. Emerging/re-emerging viral diseases & new viruses on the Indian horizon. Indian J Med Res 2019; 149(4): 447-67.
[http://dx.doi.org/10.4103/ijmr.IJMR_1239_18] [PMID: 31411169]
[3]
Tarín-Vicente EJ, Alemany A, Agud-Dios M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: A prospective observational cohort study. Lancet 2022; 400(10353): 661-9.
[http://dx.doi.org/10.1016/S0140-6736(22)01436-2] [PMID: 35952705]
[4]
Cho CT, Wenner HA. Monkeypox virus. Bacteriol Rev 1973; 37(1): 1-18.
[http://dx.doi.org/10.1128/br.37.1.1-18.1973] [PMID: 4349404]
[5]
Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med 2022; 387(19): 1783-93.
[http://dx.doi.org/10.1056/NEJMra2208860] [PMID: 36286263]
[6]
Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Acta Pathol Microbiol Scand 1959; 46(2): 156-76.
[http://dx.doi.org/10.1111/j.1699-0463.1959.tb00328.x]
[7]
Iñigo Martínez J, Gil Montalbán E, Jiménez Bueno S, et al. Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022. Euro Surveill 2022; 27(27): 2200471.
[http://dx.doi.org/10.2807/1560-7917.ES.2022.27.27.2200471] [PMID: 35801519]
[8]
Diven DG. An overview of poxviruses. J Am Acad Dermatol 2001; 44(1): 1-16.
[http://dx.doi.org/10.1067/mjd.2001.109302] [PMID: 11148468]
[9]
Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am 2019; 33(4): 1027-43.
[http://dx.doi.org/10.1016/j.idc.2019.03.001] [PMID: 30981594]
[10]
Di Giulio DB, Eckburg PB. Human monkeypox: An emerging zoonosis. Lancet Infect Dis 2004; 4(1): 15-25.
[http://dx.doi.org/10.1016/S1473-3099(03)00856-9] [PMID: 14720564]
[11]
Jezek Z, Gromyko AI, Szczeniowski MV. Human monkeypox. J Hyg Epidemiol Microbiol Immunol 1983; 27(1): 13-28.
[PMID: 6304185]
[12]
Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in basankusu territory, democratic republic of the Congo. Bull World Health Organ 1972; 46(5): 593-7.
[PMID: 4340218]
[13]
Haller SL, Peng C, McFadden G, Rothenburg S. Poxviruses and the evolution of host range and virulence. Infect Genet Evol 2014; 21: 15-40.
[http://dx.doi.org/10.1016/j.meegid.2013.10.014] [PMID: 24161410]
[14]
Kabuga AI, El Zowalaty ME. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol 2019; 91(4): 533-40.
[http://dx.doi.org/10.1002/jmv.25348] [PMID: 30357851]
[15]
Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun 2022; 131: 102855.
[http://dx.doi.org/10.1016/j.jaut.2022.102855] [PMID: 35760647]
[16]
Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution. Viruses 2020; 12(11): 1257.
[http://dx.doi.org/10.3390/v12111257] [PMID: 33167496]
[17]
Basgoz N, Brown CM, Smole SC, et al. Case 24-2022: A 31-year-old man with perianal and penile ulcers, rectal pain, and rash. N Engl J Med 2022; 387(6): 547-56.
[http://dx.doi.org/10.1056/NEJMcpc2201244] [PMID: 35704401]
[18]
Organization WH. Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022. World Health Organization 2022.
[19]
Tabarsi P. Human Monkeypox. Iran J Med Sci 2022; 47(4): 289-90.
[http://dx.doi.org/10.30476/ijms.2022.48507] [PMID: 35919078]
[20]
Heymann DL, Simpson K. The evolving epidemiology of human monkeypox: Questions still to be answered. J Infect Dis 2021; 223(11): 1839-41.
[http://dx.doi.org/10.1093/infdis/jiab135] [PMID: 33871010]
[21]
Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: Family biology matters. Emerg Microbes Infect 2022; 11(1): 1768-77.
[http://dx.doi.org/10.1080/22221751.2022.2095309] [PMID: 35751396]
[22]
Breman JG, Kalisa-Ruti , Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ 1980; 58(2): 165-82.
[PMID: 6249508]
[23]
Foster SO, Brink EW, Hutchins DL, et al. Human monkeypox. Bull World Health Organ 1972; 46(5): 569-76.
[PMID: 4340216]
[24]
Vaughan A, Aarons E, Astbury J, et al. Two cases of monkeypox imported to the united kingdom, september 2018. Euro Surveill 2018; 23(38): 1800509.
[http://dx.doi.org/10.2807/1560-7917.ES.2018.23.38.1800509] [PMID: 30255836]
[25]
Brasil P, Martins EB, Calvet GA, Werneck GL. What do we need to know about the monkeypox virus infection in humans? Cad Saude Publica 2022; 38(9): e00129222.
[http://dx.doi.org/10.1590/0102-311xen129222] [PMID: 36169515]
[26]
Ajmera KM, Goyal L, Pandit T, Pandit R. Monkeypox – An emerging pandemic. IDCases 2022; 29: e01587.
[http://dx.doi.org/10.1016/j.idcr.2022.e01587] [PMID: 35938150]
[27]
Thakur M, Das P, Sobti RC, Kaur T. Human monkeypox: Epidemiology, transmission, pathogenesis, immunology, diagnosis and therapeutics. Mol Cell Biochem 2023; 478(9): 2097-110.
[http://dx.doi.org/10.1007/s11010-022-04657-0] [PMID: 36626099]
[28]
Evans A, AlShurman BA, Sehar H, Butt ZA. Monkeypox: A Mini-review on the globally emerging orthopoxvirus. Int J Environ Res Public Health 2022; 19(23): 15684.
[http://dx.doi.org/10.3390/ijerph192315684] [PMID: 36497758]
[29]
Upadhayay S, Arthur R, Soni D, et al. Monkeypox infection: The past, present, and future. Int Immunopharmacol 2022; 113(Pt A): 109382.
[http://dx.doi.org/10.1016/j.intimp.2022.109382] [PMID: 36330915]
[30]
Yang Z. Monkeypox: A potential global threat? J Med Virol 2022; 94(9): 4034-6.
[http://dx.doi.org/10.1002/jmv.27884] [PMID: 35614026]
[31]
Yang ZS, Lin CY, Urbina AN, et al. The first case of monkeypox virus infection detected in Taiwan: Awareness and preparation. Int J Infect Dis 2022; 122: 991-5.
[http://dx.doi.org/10.1016/j.ijid.2022.07.051] [PMID: 35902024]
[32]
Jang YR, Lee M, Shin H, et al. The first case of monkeypox in the Republic of Korea. J Korean Med Sci 2022; 37(27): e224.
[http://dx.doi.org/10.3346/jkms.2022.37.e224] [PMID: 35818706]
[33]
Carvalho LB, Casadio LVB, Polly M, et al. Monkeypox virus transmission to healthcare worker through needlestick injury, Brazil. Emerg Infect Dis 2022; 28(11): 2334-6.
[http://dx.doi.org/10.3201/eid2811.221323] [PMID: 36121391]
[34]
Tusabe F, Tahir IM, Akpa CI, et al. Lessons learned from the ebola virus disease and COVID-19 Preparedness to respond to the human monkeypox virus outbreak in low-and middle-income countries. Infect Drug Resist 2022; 15: 6279-86.
[http://dx.doi.org/10.2147/IDR.S384348] [PMID: 36329989]
[35]
Standard B. US calls India s stand on Russian sanctions deeply disappointing. Available at: www. business-standard. com/article/international/us-australia-criticise-india-over-russia-talks-as-lavrov-visits-delhi-122033100171_1. html (Accessed on: 2022).
[36]
Fernandes H. Monkeypox: Another virus gone viral! Adv in Molecular Pathology 2022; 5(1): xv-xvi.
[http://dx.doi.org/10.1016/j.yamp.2022.08.003]
[37]
Vallejo-Plaza A, Rodríguez-Cabrera F, Hernando Sebastián V, et al. Mpox (formerly monkeypox) in women: Epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022. Euro Surveill 2022; 27(48): 2200867.
[http://dx.doi.org/10.2807/1560-7917.ES.2022.27.48.2200867] [PMID: 36695461]
[38]
Peters SM, Hill NB, Halepas S. Oral manifestations of monkeypox: A report of 2 cases. J Oral Maxillofac Surg 2022; 80(11): 1836-40.
[http://dx.doi.org/10.1016/j.joms.2022.07.147] [PMID: 36055370]
[39]
Meaney-Delman DM, Galang RR, Petersen BW, Jamieson DJ. A primer on monkeypox virus for Obstetrician–Gynecologists: Diagnosis, prevention, and treatment. Obstet Gynecol 2022; 140(3): 391-7.
[http://dx.doi.org/10.1097/AOG.0000000000004909] [PMID: 36356237]
[40]
Hutin YJF, Williams RJ, Malfait P, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis 2001; 7(3): 434-8.
[http://dx.doi.org/10.3201/eid0703.017311] [PMID: 11384521]
[41]
European centre for disease prevention and control. Risk assessment: Monkeypox multi-country outbreak. Stockholm: ECDC 2022.
[42]
Adalja A, Inglesby T. A novel international monkeypox outbreak. Ann Intern Med 2022; 175(8): 1175-6.
[http://dx.doi.org/10.7326/M22-1581] [PMID: 35605243]
[43]
Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis 2019; 13(10): e0007791.
[http://dx.doi.org/10.1371/journal.pntd.0007791] [PMID: 31618206]
[44]
Brown K, Leggat P. Human monkeypox: Current state of knowledge and implications for the future. Trop Med Infect Dis 2016; 1(1): 8.
[http://dx.doi.org/10.3390/tropicalmed1010008] [PMID: 30270859]
[45]
Menezes Filho ACP, Ventura MVA, Alves I, Taques AS. Monkeypox: World health emergency in 2022. Brazilian J of Sci 2022; 1(10): 5-11.
[http://dx.doi.org/10.14295/bjs.v1i10.180]
[46]
Mohapatra RK, Tuli HS, Sarangi AK, et al. Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat? Int J Surg 2022; 103: 106705.
[http://dx.doi.org/10.1016/j.ijsu.2022.106705] [PMID: 35697322]
[47]
Ranganath N, Tosh P K, Horo OJ, Sampathkumar P, Binnicker M J, Shah A S. Monkeypox 2022: Gearing up for another potential public health crisis, Mayo clinic proceedings. Elsevier 2022.
[48]
Damon IK. Status of human monkeypox: Clinical disease, epidemiology and research. Vaccine 2011; 29 (Suppl. 4): D54-9.
[http://dx.doi.org/10.1016/j.vaccine.2011.04.014] [PMID: 22185831]
[49]
Nolen LD, Osadebe L, Katomba J, et al. Extended human-to-human transmission during a monkeypox outbreak in the democratic republic of the Congo. Emerg Infect Dis 2016; 22(6): 1014-21.
[http://dx.doi.org/10.3201/eid2206.150579] [PMID: 27191380]
[50]
Sapkal A, Agrawal S. Monkeypox: The re-emerging terror. Cureus 2022; 14(8): e28597.
[PMID: 36185856]
[51]
Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: monkeypox viruses. J Gen Virol 2005; 86(10): 2661-72.
[http://dx.doi.org/10.1099/vir.0.81215-0] [PMID: 16186219]
[52]
Reynolds M, McCollum A, Nguete B, Shongo Lushima R, Petersen B. Improving the care and treatment of monkeypox patients in low-resource settings: Applying evidence from contemporary biomedical and smallpox biodefense research. Viruses 2017; 9(12): 380.
[http://dx.doi.org/10.3390/v9120380] [PMID: 29231870]
[53]
Sah R, Abdelaal A, Reda A, et al. Monkeypox Viral Detection In Semen Specimens of Confirmed Cases: A Systematic Review and Meta-Analysis. Res Square 2022.
[http://dx.doi.org/10.21203/rs.3.rs-1970704/v1]
[54]
Moore MJ, Rathish B, Zahra F. Monkeypox.StatPearls. StatPearls Publishing 2022.
[55]
Dhawan M, Priyanka , Choudhary OP. Emergence of monkeypox: Risk assessment and containment measures. Travel Med Infect Dis 2022; 49: 102392.
[http://dx.doi.org/10.1016/j.tmaid.2022.102392] [PMID: 35752293]
[56]
Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 2018; 6: 241.
[http://dx.doi.org/10.3389/fpubh.2018.00241] [PMID: 30234087]
[57]
Cohen J. Monkeypox outbreak questions intensify as cases soar. Sci 2022; 376(6596): 902-3.
[http://dx.doi.org/10.1126/science.add1583] [PMID: 35617408]
[58]
Koenig KL, Beÿ CK, Marty AM. Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission. One Health 2022; 15: 100410.
[http://dx.doi.org/10.1016/j.onehlt.2022.100410] [PMID: 36249992]
[59]
Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: A re-emergent threat to humans. Virol Sin 2022; 37(4): 477-82.
[http://dx.doi.org/10.1016/j.virs.2022.07.006] [PMID: 35820590]
[60]
Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet 1986; 327(8472): 98-9.
[http://dx.doi.org/10.1016/S0140-6736(86)90748-8] [PMID: 2867342]
[61]
Fine PEM, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988; 17(3): 643-50.
[http://dx.doi.org/10.1093/ije/17.3.643] [PMID: 2850277]
[62]
Centers for Disease Control and Prevention. Infection prevention and control of mpox in healthcare settings. 2022. Available at: https://www. https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html
[63]
Kozlov M. Monkeypox outbreaks: 4 key questions researchers have. Nature 2022; 606(7913): 238-9.
[http://dx.doi.org/10.1038/d41586-022-01493-6] [PMID: 35624160]
[64]
Long B, Koyfman A, Gottlieb M, et al. Monkeypox: A focused narrative review for emergency medicine clinicians. Am J Emerg Med 2022; 61: 34-43.
[http://dx.doi.org/10.1016/j.ajem.2022.08.026] [PMID: 36030595]
[65]
Hubach RD, Owens C. Findings on the monkeypox exposure mitigation strategies employed by men who have sex with men and transgender women in the United States. Arch Sex Behav 2022; 51(8): 3653-8.
[http://dx.doi.org/10.1007/s10508-022-02423-3] [PMID: 36103027]
[66]
Hutson C L, Carroll D S, Gallardo-Romero N, et al. Comparison of monkeypox virus clade kinetics and pathology within the prairie dog animal model using a serial sacrifice study design. Biomed Res Int 2015; 2015: 965710.
[http://dx.doi.org/10.1155/2015/965710]
[67]
Vivancos R, Anderson C, Blomquist P, et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Euro Surveill 2022; 27(22): 2200422.
[http://dx.doi.org/10.2807/1560-7917.ES.2022.27.22.2200422] [PMID: 35656834]
[68]
Osadebe L, Hughes CM, Shongo Lushima R, et al. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo. PLoS Negl Trop Dis 2017; 11(9): e0005857.
[http://dx.doi.org/10.1371/journal.pntd.0005857] [PMID: 28892474]
[69]
van Nispen C, Reffett T, Long B, Gottlieb M, Frawley TC. Diagnosis and management of monkeypox: A review for the emergency clinician. Ann Emerg Med 2022; 81(1): 20-30.
[http://dx.doi.org/10.1016/j.annemergmed.2022.07.014] [PMID: 36117012]
[70]
Bosworth A, Wakerley D, Houlihan CF, Atabani SF. Monkeypox: An old foe, with new challenges. Infect Prev Pract 2022; 4(3): 100229.
[http://dx.doi.org/10.1016/j.infpip.2022.100229] [PMID: 35847384]
[71]
Reynolds MG, Yorita KL, Kuehnert MJ, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 2006; 194(6): 773-80.
[http://dx.doi.org/10.1086/505880] [PMID: 16941343]
[72]
Control CD. Prevention, Monkeypox and smallpox vaccine guidance. CDC 2022. Availabel at: https://www. cdc. gov/poxvirus/monkeypox/clinicians/smallpox-vaccine. html
[73]
Organization WH. Available at: https://www. who. int/news-room/fact-sheets/detail/ebola-virus-disease (Accessed on: 2020).
[74]
Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs 2022; 82(9): 957-63.
[http://dx.doi.org/10.1007/s40265-022-01742-y] [PMID: 35763248]
[75]
Iannone V, Ciccullo A, Farinacci D, et al. Early use of tecovirimat in a young man with severe mpox skin lesions: A case report. J Med Virol 2023; 95(2): e28528.
[http://dx.doi.org/10.1002/jmv.28528] [PMID: 36695663]
[76]
Russo AT, Grosenbach DW, Chinsangaram J, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther 2021; 19(3): 331-44.
[http://dx.doi.org/10.1080/14787210.2020.1819791] [PMID: 32882158]
[77]
Grosenbach DW, Honeychurch K, Rose EA, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med 2018; 379(1): 44-53.
[http://dx.doi.org/10.1056/NEJMoa1705688] [PMID: 29972742]
[78]
Quenelle DC, Buller RML, Parker S, et al. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother 2007; 51(2): 689-95.
[http://dx.doi.org/10.1128/AAC.00879-06] [PMID: 17116683]
[79]
Vora S, Damon I, Fulginiti V, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 2008; 46(10): 1555-61.
[http://dx.doi.org/10.1086/587668] [PMID: 18419490]
[80]
Control CD. Household transmission of vaccinia virus from contact with a military smallpox vaccinee--Illinois and Indiana, 2007. MMWR Morb Mortal Wkly Rep 2007; 56(19): 478-81.
[PMID: 17510612]
[81]
Lederman E, Groff H, Warkentien T, et al. Progressive vaccinia in a military smallpox vaccinee - United States, 2009. MMWR Morb Mortal Wkly Rep 2009; 58(19): 532-6.
[PMID: 19478722]
[82]
Food U, Administration D. FDA approves drug to treat smallpox. Erişim tarihi 2022. Available at: www. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-smallpox
[83]
Lanier R, Trost L, Tippin T, et al. Development of CMX001 for the treatment of poxvirus infections. Viruses 2010; 2(12): 2740-62.
[http://dx.doi.org/10.3390/v2122740] [PMID: 21499452]
[84]
Monkeypox and smallpox vaccine guidance. 2022.
[85]
Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl Trop Dis 2022; 16(2): e0010141.
[http://dx.doi.org/10.1371/journal.pntd.0010141] [PMID: 35148313]
[86]
Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: A retrospective observational study in the UK. Lancet Infect Dis 2022; 22(8): 1153-62.
[http://dx.doi.org/10.1016/S1473-3099(22)00228-6] [PMID: 35623380]
[87]
Mazurkov OY, Kabanov AS, Shishkina LN, et al. New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol 2016; 97(5): 1229-39.
[http://dx.doi.org/10.1099/jgv.0.000422] [PMID: 26861777]
[88]
McCollum AM, Damon IK. Human Monkeypox. Clin Infect Dis 2014; 58(2): 260-7.
[http://dx.doi.org/10.1093/cid/cit703] [PMID: 24158414]
[89]
Hutson CL, Kondas AV, Mauldin MR, et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. MSphere 2021; 6(1): e00927-20.
[http://dx.doi.org/10.1128/mSphere.00927-20] [PMID: 33536322]
[90]
Hoy SM. Patisiran: First global approval. Drugs 2018; 78(15): 1625-31.
[http://dx.doi.org/10.1007/s40265-018-0983-6] [PMID: 30251172]
[91]
Hraib M, Jouni S, Albitar MM, Alaidi S, Alshehabi Z. The outbreak of monkeypox 2022: An overview. Ann Med Surg 2022; 79: 104069.
[http://dx.doi.org/10.1016/j.amsu.2022.104069] [PMID: 35860140]
[92]
Isidro J, Borges V, Pinto M, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med 2022; 28(8): 1569-72.
[http://dx.doi.org/10.1038/s41591-022-01907-y]
[93]
Khalil A, Samara A, O’Brien P, et al. Monkeypox vaccines in pregnancy: Lessons must be learned from COVID-19. Lancet Glob Health 2022; 10(9): e1230-1.
[http://dx.doi.org/10.1016/S2214-109X(22)00284-4] [PMID: 35772413]
[94]
Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis 2017; 216(7): 824-8.
[http://dx.doi.org/10.1093/infdis/jix260] [PMID: 29029147]
[95]
Ganapthy D, Sekaran S. Monkeypox treatment options: Current status of antiviral drugs. Int J Surg 2023; 109(3): 562-3.
[http://dx.doi.org/10.1097/JS9.0000000000000147] [PMID: 37093094]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy